Homology Medicines, Inc.
Homology Medicines, Inc. (FIXX) Stock Overview
Explore Homology Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3M
P/E Ratio
0.39
EPS (TTM)
$-35.10
ROE
16.30%
FIXX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Homology Medicines, Inc. (FIXX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.39 and a market capitalization of 3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.